Banque Pictet & Cie Sa Boston Scientific Corp Transaction History

Banque Pictet & Cie Sa

$13.1 Billion
Q3 2024

A detailed history of Banque Pictet & Cie Sa transactions in Boston Scientific Corp stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 400,387 shares of BSX stock, worth $35.6 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

400,387

Previous 372,048 7.62%

Holding current value

$35.6 Million

Previous $28.7 Million 17.11%

% of portfolio

0.26%

Previous 0.26%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$72.96 - $84.0 $2.07 Million - $2.38 Million	28,339 Added 7.62%	400,387 $33.6 Million
Q2 2024 Jul 25, 2024	BUY	$67.33 - $77.71 $946,861 - $1.09 Million	14,063 Added 3.93%	372,048 $28.7 Million
Q1 2024 May 06, 2024	SELL	$57.6 - $68.62 $658,310 - $784,257	-11,429 Reduced 3.09%	357,985 $24.5 Million
Q4 2023 Feb 09, 2024	SELL	$48.64 - $57.81 $1.91 Million - $2.27 Million	-39,183 Reduced 9.59%	369,414 $21.4 Million
Q3 2023 Nov 27, 2023	SELL	$50.19 - $54.68 $4.03 Million - $4.39 Million	-80,297 Reduced 16.42%	408,597 $21.6 Million
Q3 2023 Nov 02, 2023	BUY	$50.19 - $54.68 $1.16 Million - $1.26 Million	23,134 Added 4.97%	488,894 $25.8 Million
Q2 2023 Aug 04, 2023	BUY	$49.72 - $54.64 $7.13 Million - $7.84 Million	143,494 Added 44.53%	465,760 $25.2 Million
Q1 2023 May 01, 2023	SELL	$45.09 - $50.03 $348,545 - $386,731	-7,730 Reduced 2.34%	322,266 $16.1 Million
Q4 2022 Feb 06, 2023	BUY	$39.56 - $47.22 $126,631 - $151,151	3,201 Added 0.98%	329,996 $0
Q3 2022 Nov 10, 2022	SELL	$36.71 - $109.66 $269,855 - $806,110	-7,351 Reduced 2.2%	326,795 $12.7 Billion
Q2 2022 Aug 08, 2022	SELL	$35.24 - $47.1 $297,742 - $397,947	-8,449 Reduced 2.47%	334,146 $12.5 Million
Q1 2022 May 04, 2022	SELL	$40.9 - $45.1 $1.43 Million - $1.58 Million	-34,951 Reduced 9.26%	342,595 $15.2 Million
Q4 2021 Feb 02, 2022	BUY	$38.07 - $44.87 $1.68 Million - $1.98 Million	44,147 Added 13.24%	377,546 $16 Million
Q3 2021 Nov 10, 2021	SELL	$41.23 - $45.88 $2.38 Million - $2.65 Million	-57,698 Reduced 14.75%	333,399 $14.5 Million
Q2 2021 Aug 12, 2021	SELL	$38.58 - $44.24 $872,679 - $1 Million	-22,620 Reduced 5.47%	391,097 $16.7 Million
Q1 2021 May 11, 2021	SELL	$35.27 - $39.67 $795,197 - $894,399	-22,546 Reduced 5.17%	413,717 $16 Million
Q4 2020 Feb 10, 2021	BUY	$33.15 - $41.97 $6.25 Million - $7.91 Million	188,505 Added 76.08%	436,263 $15.7 Million
Q3 2020 Nov 10, 2020	SELL	$34.44 - $42.23 $1.29 Million - $1.58 Million	-37,418 Reduced 13.12%	247,758 $9.47 Million
Q2 2020 Aug 13, 2020	BUY	$30.19 - $39.11 $1.93 Million - $2.5 Million	64,010 Added 28.94%	285,176 $10 Million
Q1 2020 Apr 30, 2020	BUY	$25.83 - $45.71 $1.85 Million - $3.28 Million	71,661 Added 47.93%	221,166 $7.22 Million
Q4 2019 Feb 03, 2020	BUY	$37.87 - $45.37 $2.23 Million - $2.68 Million	59,007 Added 65.2%	149,505 $6.76 Million
Q3 2019 Nov 08, 2019	BUY	$40.31 - $43.45 $1.05 Million - $1.13 Million	26,000 Added 40.31%	90,498 $3.68 Million
Q2 2019 Aug 07, 2019	BUY	$34.91 - $42.98 $929,583 - $1.14 Million	26,628 Added 70.31%	64,498 $2.77 Million
Q1 2019 May 02, 2019	BUY	$32.91 - $40.75 $195,814 - $242,462	5,950 Added 18.64%	37,870 $1.45 Million
Q3 2018 Nov 07, 2018	SELL	$32.83 - $38.63 $804,335 - $946,435	-24,500 Reduced 43.42%	31,920 $1.23 Million
Q2 2018 Aug 09, 2018	BUY	$26.84 - $34.32 $331,474 - $423,852	12,350 Added 28.02%	56,420 $1.85 Million
Q1 2018 May 09, 2018	BUY	$25.2 - $28.54 $684,684 - $775,431	27,170 Added 160.77%	44,070 $1.2 Million
Q4 2017 Feb 09, 2018	BUY	$24.79 - $29.8 $418,951 - $503,620	16,900	16,900 $419,000

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $127B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.

Account

Banque Pictet & Cie Sa Boston Scientific Corp Transaction History